Head of Investor Relations
Travere Therapeutics, Inc. (TVTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Travere Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TVTX alertsNivi Nehra is recorded as Head of Investor Relations at Travere Therapeutics, Inc. (TVTX). Nivi Nehra has spoken on 6 earnings calls and 1 other investor event across 1 company, most recently for Travere Therapeutics, Inc. on August 4, 2026. Travere Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Travere Therapeutics, Inc. includes Bradley Campbell (CEO and Board Member), Bradley L. Campbell (CEO and Board Member), Christopher Cline (CFO) and 7 others.
“Good afternoon, and welcome to Trevier Therapeutics' second quarter 2026 financial results and corporate update call. Thank you all for joining. Today's call will be led by Dr. Eric DeBay, our President and Chief Executive Officer.”
“Good afternoon, and welcome to Trevier Therapeutics' First Quarter 2026 Financial Results and Corporate Update Call. Thank you all for joining. Today's call will be led by Dr. Eric Dubay, our President and Chief Executive Officer.”
“Earlier today, we announced the FDA has approved Bill Spari and FSGS. A copy of the press release, along with the slides that we'll be referencing on today's call, can be found on our corporate website.”
“Good afternoon and welcome to Tervere Therapeutics' 4th Quarter and Full Year 2025 Financial Results and Corporate Update Call. Thank you all for joining. Today's call will be led by Dr. Eric DuVay, our President and Chief Executive Officer.”
“Good afternoon, and welcome to Travere Therapeutics' Third Quarter 2025 Financial Results and Corporate Update Call. Thank you all for joining. Today's call will be led by Dr. Eric Dube, our President and Chief Executive Officer.”
Biotechnology · Healthcare
Head of Investor Relations
